Tokyo, Japan

Etsuro Ogata

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2009.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Etsuro Ogata: Innovator in Cancer Diagnosis

Introduction

Etsuro Ogata is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the area of cancer treatment. His innovative approach focuses on improving the diagnosis of bone metastasis in malignant tumors.

Latest Patents

Etsuro Ogata holds a patent for a method that diagnoses bone metastasis of malignant tumors. This patent addresses the challenges associated with diagnosing conditions such as breast cancer, prostatic cancer, and lung cancer. The method utilizes markers that reflect the activity of osteoblasts and osteoclasts, providing a more accurate assessment of the disease.

Career Highlights

Throughout his career, Etsuro Ogata has demonstrated a commitment to advancing medical technology. His work has the potential to improve treatment outcomes for patients suffering from various forms of cancer. With a focus on innovative diagnostic methods, he continues to contribute to the medical field.

Collaborations

Etsuro Ogata has collaborated with esteemed colleagues, including Shunji Takahashi and Mitsuru Koizumi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Etsuro Ogata's contributions to cancer diagnosis exemplify the impact of innovation in medicine. His patented method for diagnosing bone metastasis represents a significant advancement in the field. Through his work, he continues to pave the way for improved cancer treatment and patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…